Scientists have developed nanoparticles that, when injected into the eye, can restore vision after retinal damage by replacing lost photoreceptors. This technology does not require surgery and is suitable for various causes of vision loss.
Scientists have developed a flexible eye implant that enables blind mice to perceive infrared light without damaging eye tissue. This new technology could expand treatment options for blindness, but its effectiveness and perception in humans remain unknown.
For the first time, the technology of epigenetic cell rejuvenation, previously tested successfully on animals, is moving into clinical trials in humans. The new drug ER-100 could pave the way for restoring retinal cell function and treating age-related eye diseases.
The eyes of vertebrates developed from neural tissue rather than skin, combining two evolutionary lines of light-sensitive cells. Recent research reveals the stages of this unique process and highlights the role of the pineal gland.
The study revealed that deep-sea fish larvae use unique hybrid cells for vision, combining the properties of both daytime and nighttime receptors. This discovery highlights the remarkable flexibility of evolution in adapting to life in darkness.
In a clinical study, a miniature implant and smart glasses helped most patients with severe macular degeneration partially regain their ability to read. This technology enables users to distinguish shapes and outlines, significantly improving the quality of life for people with incurable vision loss.